Lignoceric Acid

Lignoceric Acid (CAS No.: 557-59-5) is a very long-chain saturated fatty acid that is endogenously synthesized during mammalian brain development and is a constituent of complex lipids such as cerebrosides, reflecting its role in membrane structure and neural tissue maturation. As a component of very-long-chain fatty acid metabolism, lignoceric acid is closely associated with peroxisomal β-oxidation pathways, and impaired degradation of this lipid species contributes to the pathophysiology of peroxisomal disorders, including Zellweger spectrum disorders and X-linked adrenoleukodystrophy, making it a valuable biochemical marker and mechanistic probe in neurodegenerative disease research. In addition to its endogenous origin, it can also arise as a by-product of lignin biosynthesis, linking it to broader metabolic and biochemical processes. Although it does not function as a classical receptor-targeting ligand, lignoceric acid modulates lipid metabolic networks and membrane composition, indirectly influencing cellular signaling and homeostasis. Experimental studies typically employ lignoceric acid in cell-based and animal models to investigate lipid accumulation, peroxisomal dysfunction, and associated neurotoxicity, with concentrations varying depending on the specific model and study design, generally within micromolar ranges for in vitro systems. Its relevance in disease modeling and metabolic studies supports its application in drug discovery efforts aimed at targeting lipid metabolism and peroxisomal function.